Atorvastatin/Fenofibrate 40/100 mg Fixed-Dose Combination Tablet (LCP-AtorFen 40/100 mg) Offers Improved Efficacy Over 40 mg Atorvastatin and Higher Dose 145 mg Fenofibrate in Patients with Dyslipidemia

被引：0
|
作者：
Davidson, Michael H. [1 ]
Rooney, Michael [1 ]
Drucker, Joan [1 ]
Griffin, H. E. [2 ]
Beckert, Michael [3 ]
机构：
[1] Fladiant Rsch Inc, Chicago, IL USA
[2] LifeCycle Pharma Inc, New York, NY USA
[3] LifeCycle Pharma AS, Horsholm, Denmark
来源：
CIRCULATION | 2008年 / 118卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S1139 / S1139
页数：1
相关论文
共 29 条
  • [1] To study the effect of high dose Atorvastatin 40 mg versus 80 mg in patients with dyslipidemia
    Agrawal, Deepak
    Manchanda, S. C.
    Sawhney, J. P. S.
    Kandpal, Bhuwanesh
    Jain, Rajneesh
    Mehta, Ashwani
    Mohanty, Arun
    Passey, Rajiv
    Makhija, Aman
    Sharma, Manish Kr
    INDIAN HEART JOURNAL, 2018, 70 : S8 - S12
  • [2] Safety of a Fixed-Dose Combination of Fenofibrate/Pravastatin 160 mg/40 mg in Patients with Mixed HyperlipidaemiaA Pooled Analysis from a Database of Clinical Trials
    Michel Farnier
    David Marcereuil
    Sophie De Niet
    Jean Ducobu
    Armin Steinmetz
    Kjetil Retterstøl
    Leszek Bryniarski
    Albert Császár
    Francis Vanderbist
    Clinical Drug Investigation, 2012, 32 : 281 - 291
  • [3] Safety of a Fixed-Dose Combination of Fenofibrate/Pravastatin 160 mg/40 mg in Patients with Mixed Hyperlipidaemia A Pooled Analysis from a Database of Clinical Trials
    Farnier, Michel
    Marcereuil, David
    De Niet, Sophie
    Ducobu, Jean
    Steinmetz, Armin
    Retterstol, Kjetil
    Bryniarski, Leszek
    Csaszar, Albert
    Vanderbist, Francis
    CLINICAL DRUG INVESTIGATION, 2012, 32 (04) : 281 - 291
  • [4] Comparison of the Efficacy and Safety of Atorvastatin 40 mg/ω-3 Fatty Acids 4 g Fixed-dose Combination and Atorvastatin 40 mg Monotherapy in Hypertriglyceridemic Patients who Poorly Respond to Atorvastatin 40 mg Monotherapy: An 8-week, Multicenter, Randomized, Double-blind Phase III Study
    Woo, Jong Shin
    Hong, Soon Jun
    Cha, Dong Hoon
    Kim, Kee Sik
    Kim, Moo Hyun
    Lee, Jun-Won
    Jeong, Myung Ho
    Jeong, Jin-Ok
    Lee, Jun-Hee
    Jeon, Doo Soo
    Cho, Eun Joo
    Kim, Soon Kil
    Kwan, Jun
    Park, Chang Gyu
    Lee, Hae Young
    Hong, Taek Jong
    Shin, Jinho
    Youn, Ho Joong
    Jeon, Dong Woon
    Chung, Wook Jin
    Jeong, Ju Cheol
    Kim, Chong Jin
    CLINICAL THERAPEUTICS, 2021, 43 (08) : 1419 - 1430
  • [5] The 40-mg dose of eletriptan: comparative efficacy and tolerability versus sumatriptan 100 mg
    Diener, HC
    Ryan, R
    Sun, W
    Hettiarachchi, J
    EUROPEAN JOURNAL OF NEUROLOGY, 2004, 11 (02) : 125 - 134
  • [6] Safety, tolerability, and efficacy of a fixed-dose combination of olmesartan 40 mg and hydrochlorothiazide 12.5/25 mg in daily practice
    Bramlage, Peter
    Zemmrich, Claudia
    Ketelhut, Reinhard
    Wolf, Wolf-Peter
    Fronk, Eva-Maria
    Schmieder, Roland E.
    VASCULAR HEALTH AND RISK MANAGEMENT, 2013, 9 : 475 - 483
  • [7] Efficacy and Tolerability of Atorvastatin/Fenofibrate Fixed-Dose Combination Tablet Compared With Atorvastatin and Fenofibrate Monotherapies in Patients With Dyslipidemia: A 12-Week, Multicenter, Double-Blind, Randomized, Parallel-Group Study
    Davidson, Michael H.
    Rooney, Michael W.
    Drucker, Joan
    Griffin, H. Eugene
    Oosman, Sonia
    Beckert, Michael
    CLINICAL THERAPEUTICS, 2009, 31 (12) : 2824 - 2838
  • [8] EFFICACY AND SAFETY OF FENOFIBRATE 160 MG IN COMBINATION WITH PRAVASTATIN 40 MG IN TYPE 2 DIABETIC PATIENTS WITH COMBINED HYPERLIPIDEMIA AND WITHOUT CARDIOVASCULAR DISEASE
    Farnier, Michel
    Steinmetz, Armin
    Retterstol, Kjetil
    Dluzniewski, Miroslaw
    Csazar, Albert
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (10)
  • [9] Comparison of the Pharmacokinetics of Highly Variable Drugs in Healthy Subjects Using a Partial Replicated Crossover Study: A Fixed-Dose Combination of Fimasartan 120 mg and Atorvastatin 40 mg versus Separate Tablets
    Hwang, Jun Gi
    Yu, Kyung-Sang
    Lee, SeungHwan
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2020, 14 : 1953 - 1961
  • [10] Fixed-Dose Combination Fenofibrate/Pravastatin 160/40 mg Versus Simvastatin 20 mg Monotherapy in Adults With Type 2 Diabetes and Mixed Hyperlipidemia Uncontrolled With Simvastatin 20 mg: A Double-Blind, Randomized Comparative Study
    Farnier, Michel
    Steinmetz, Armin
    Retterstol, Kjetil
    Csaszar, Albert
    CLINICAL THERAPEUTICS, 2011, 33 (01) : 1 - 12
123